MOLECULAR PARTNERS AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
5
- +1 vs. Q1 2026
- Total value $13.81M
Superinvestors holding MOLN
0
- None of the superinvestors held MOLN at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MOLN insiders, newest first.
No open-market purchases or sales by MOLN insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MOLN at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,221,494 | $8.6M | 0.18% | 00.0% | Unchanged |
| BVF INC/IL | 1,353,968 | $5.15M | 0.13% | 00.0% | Unchanged |
| CITADEL ADVISORS LLC | 17,179 | $65.28K | 0.00% | +17,179 | New |
| MORGAN STANLEY | 367 | $1.42K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 279 | $1.08K | 0.00% | +279 | New |